SJS Investment Consulting’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.55K Buy
122
+107
+713% +$7.3K ﹤0.01% 1098
2026
Q1
$970 Sell
15
-15
-50% -$1.06K ﹤0.01% 1485
2025
Q4
$2.02K Buy
30
+19
+173% +$1.28K ﹤0.01% 1144
2025
Q3
$807 Hold
11
﹤0.01% 1084
2025
Q2
$573 Sell
11
-9
-45% -$512 ﹤0.01% 1067
2025
Q1
$1.28K Hold
20
﹤0.01% 911
2024
Q4
$957 Sell
20
-3
-13% -$154 ﹤0.01% 1012
2024
Q3
$1.32K Buy
23
+2
+10% +$115 ﹤0.01% 968
2024
Q2
$1.1K Hold
21
﹤0.01% 992
2024
Q1
$855 Sell
21
-4
-16% -$150 ﹤0.01% 1099
2023
Q4
$924 Buy
25
+4
+19% +$151 ﹤0.01% 986
2023
Q3
$803 Buy
21
+1
+5% +$41 ﹤0.01% 1026
2023
Q2
$722 Buy
20
+16
+400% +$546 ﹤0.01% 1025
2023
Q1
$153 Sell
4
-19
-83% -$891 ﹤0.01% 1403
2022
Q4
$1.31K Buy
23
+11
+92% +$563 ﹤0.01% 820
2022
Q3
$0 Buy
+12
New +$530 ﹤0.01% 1234
2022
Q1
$0 Buy
+3
New +$107 ﹤0.01% 964

Other funds holding HALO

SJS Investment Consulting's HALO Position: Q2 2026 in Review

SJS Investment Consulting increased its Halozyme (HALO) stake by 713% in Q2 2026, buying an estimated $7.3K and bringing the position to 122 shares worth $9.55K. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

SJS Investment Consulting first reported a position in HALO in Q1 2022 and has held it in 17 quarters since. 369 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • SJS Investment Consulting held 122 shares of Halozyme worth $9.55K as of Q2 2026.
  • SJS Investment Consulting bought 107 Halozyme shares in Q2 2026, an estimated $7.3K.
  • Halozyme made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1098 holding.
  • SJS Investment Consulting first reported a position in Halozyme in Q1 2022 and has held it in 17 quarters since.
  • 369 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.